Physical Activity of Participants in Different Age Groups
NCT ID: NCT06622785
Last Updated: 2024-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
330 participants
OBSERVATIONAL
2022-11-01
2024-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity and Physical Fitness Parameters in COVID-19 Lockdown
NCT04738721
Perceived Barriers and Facilitators to Physical Activity in Turkish Youth
NCT07320131
THE EFFECT OF THE EDUCATION PROGRAM BASED ON THE HEALTH BELIEF MODEL ON THE PHYSICAL ACTIVITY BELIEFS AND BEHAVIOR OF FIRST YEAR STUDENTS OF THE FACULTY OF NURSING
NCT06457893
The Effect of Exercise-Oriented Training on Physical Activity Level and Exercise Awareness in Overweight and Obese Women
NCT06123273
Effects of Social Media Addiction on Physical Activity Level and Exercise Capacity in University Students
NCT06187766
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
People aged 18-29 years
Physical activity
Data were collected using a International Physical Activity Questionnaire-Short Form (IPAQ-SF)
Exercise Benefits
Data were collected using a Exercise Benefits/Barriers Scale .
Group 2
People aged 30-44 years
Physical activity
Data were collected using a International Physical Activity Questionnaire-Short Form (IPAQ-SF)
Exercise Benefits
Data were collected using a Exercise Benefits/Barriers Scale .
Group 3
People aged 45-60 years
Physical activity
Data were collected using a International Physical Activity Questionnaire-Short Form (IPAQ-SF)
Exercise Benefits
Data were collected using a Exercise Benefits/Barriers Scale .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical activity
Data were collected using a International Physical Activity Questionnaire-Short Form (IPAQ-SF)
Exercise Benefits
Data were collected using a Exercise Benefits/Barriers Scale .
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Those with incomplete evaluation forms
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara Yildirim Beyazıt University
OTHER
Nigde Omer Halisdemir University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asli Demirtaş
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gürkan Demirtaş, Msc
Role: PRINCIPAL_INVESTIGATOR
Niğde Ömer Halisdemir University
Arife Akbulut Bayrak, Msc
Role: PRINCIPAL_INVESTIGATOR
Ankara Yildirim Beyazıt University
Havva Sümeyye Eroğlu, Msc
Role: PRINCIPAL_INVESTIGATOR
Gazi University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Niğde Ömer Halisdemir University
Niğde, Bor, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06.10.2022-1089
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.